Case one. Bleomycin cutaneous toxicity.

Mullai, N.; Khokha, N; Shiomoto, Gail

doi:10.1200/jco.1998.16.4.1625

Search citation statements

Order By: Relevance

Paper Sections

Select...

'Flagellate' Erythema2

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2005

2013

Publication Types

Select...

Article3

Other1

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To date a number of cases with bleomycin‐induced flagellate erythema have been reported 10–28 . Additionally, an unusual case of reticular and linear hyperpigmentation has been reported 29 .…”

Section: Bleomycin‐induced Flagellate Erythemamentioning

confidence: 99%

Flagellate erythema

Yamamoto¹,

Nishioka²

2005

Int J Dermatology

View full text Add to dashboard Cite

Section: Bleomycin‐induced Flagellate Erythemamentioning

confidence: 99%

Flagellate erythema

Yamamoto¹,

Nishioka²

2005

Int J Dermatology

View full text Add to dashboard Cite

“…2). [39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] Additionally, an unusual case of reticular and linear hyperpigmentation was reported. 58 The incidence rate was shown to be 8-66% in patients treated with bleomycin.…”

Section: 'Flagellate' Erythemamentioning

confidence: 99%

Bleomycin and the skin

Yamamoto

2006

British Journal of Dermatology

121

111

View full text Add to dashboard Cite

Bleomycin is frequently used as a chemotherapeutic agent to treat various kinds of malignancy. However, the cytotoxic effects of bleomycin cause a number of adverse responses, in particular in the lung and the skin. Bleomycin is used by dermatologists as a treatment for various skin cancers, recalcitrant warts, keloid and hypertrophic scars. This article discusses the use of bleomycin for various skin disorders, as well as the risk factors and cutaneous side-effects resulting from its use.

show abstract